share_log

Exelixis' (NASDAQ:EXEL) 23% Return Outpaced the Company's Earnings Growth Over the Same One-year Period

Exelixis' (NASDAQ:EXEL) 23% Return Outpaced the Company's Earnings Growth Over the Same One-year Period

Exelixis(纳斯达克股票代码:EXEL)23%的回报率超过了公司同期的收益增长
Simply Wall St ·  02/26 07:28

We believe investing is smart because history shows that stock markets go higher in the long term. But if you choose that path, you're going to buy some stocks that fall short of the market. Over the last year the Exelixis, Inc. (NASDAQ:EXEL) share price is up 23%, but that's less than the broader market return. Zooming out, the stock is actually down 3.5% in the last three years.

我们认为投资是明智之举,因为历史表明,从长远来看,股市会走高。但是,如果你选择这条道路,你将买入一些不符合市场的股票。去年,Exelixis公司(纳斯达克股票代码:EXEL)的股价上涨了23%,但低于整个市场的回报率。放大,股票实际上是 向下 在过去三年中为3.5%。

Since the stock has added US$318m to its market cap in the past week alone, let's see if underlying performance has been driving long-term returns.

由于该股仅在过去一周的市值就增加了3.18亿美元,因此让我们看看基础表现是否推动了长期回报。

While markets are a powerful pricing mechanism, share prices reflect investor sentiment, not just underlying business performance. One imperfect but simple way to consider how the market perception of a company has shifted is to compare the change in the earnings per share (EPS) with the share price movement.

虽然市场是一种强大的定价机制,但股价反映了投资者的情绪,而不仅仅是潜在的业务表现。考虑市场对公司的看法发生了怎样的变化的一种不完美但简单的方法是将每股收益(EPS)的变化与股价走势进行比较。

During the last year Exelixis grew its earnings per share (EPS) by 15%. This EPS growth is significantly lower than the 23% increase in the share price. So it's fair to assume the market has a higher opinion of the business than it a year ago.

去年,Exelixis的每股收益(EPS)增长了15%。每股收益的增长明显低于股价23%的涨幅。因此,可以公平地假设市场对该业务的看法比一年前更高。

You can see below how EPS has changed over time (discover the exact values by clicking on the image).

你可以在下面看到 EPS 是如何随着时间的推移而变化的(点击图片发现确切的值)。

earnings-per-share-growth
NasdaqGS:EXEL Earnings Per Share Growth February 26th 2024
纳斯达克GS:EXEL每股收益增长 2024年2月26日

We know that Exelixis has improved its bottom line lately, but is it going to grow revenue? This free report showing analyst revenue forecasts should help you figure out if the EPS growth can be sustained.

我们知道Exelixis最近提高了利润,但是它会增加收入吗?这份显示分析师收入预测的免费报告应帮助您弄清楚每股收益的增长是否可以持续。

A Different Perspective

不同的视角

Exelixis shareholders are up 23% for the year. But that return falls short of the market. But at least that's still a gain! Over five years the TSR has been a reduction of 0.9% per year, over five years. So this might be a sign the business has turned its fortunes around. Most investors take the time to check the data on insider transactions. You can click here to see if insiders have been buying or selling.

Exelixis的股东今年增长了23%。但是这种回报不及市场。但至少这还是个好处!在过去的五年中,股东总回报率在五年内每年下降0.9%。因此,这可能表明该企业已经扭转了命运。大多数投资者花时间检查内幕交易数据。你可以点击这里查看内部人士是否在买入或卖出。

If you like to buy stocks alongside management, then you might just love this free list of companies. (Hint: insiders have been buying them).

如果你想与管理层一起购买股票,那么你可能会喜欢这份免费的公司名单。(提示:业内人士一直在购买它们)。

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on American exchanges.

请注意,本文引用的市场回报反映了目前在美国交易所交易的股票的市场加权平均回报。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

对这篇文章有反馈吗?对内容感到担忧?直接联系我们。 或者,给编辑团队 (at) simplywallst.com 发送电子邮件。
Simply Wall St的这篇文章本质上是笼统的。我们仅使用公正的方法根据历史数据和分析师的预测提供评论,我们的文章无意作为财务建议。它不构成买入或卖出任何股票的建议,也没有考虑到您的目标或财务状况。我们的目标是为您提供由基本数据驱动的长期重点分析。请注意,我们的分析可能不考虑最新的价格敏感型公司公告或定性材料。简而言之,华尔街没有持有任何上述股票的头寸。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发